Inspire IVF Adjusts IPO Fund Allocation, Strategizes for Risk Diversification Venturing into High-Potential Non-Healthcare Businesses Through Subsidiary “M22”
Inspire IVF Public Company Limited (IVF) announced key decisions from its Annual General Meeting of Shareholders, held on April 17, 2025. These include approval for an adjusted use of IPO proceeds,…